Direktorat Registrasi ObatValid

XTANDI

BPOM Number: DKI2620100917B1
Approved: 23 June 2026
Expiry: 23 June 2031
Form: TABLET SALUT SELAPUT

About This Registration

XTANDI is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI2620100917B1. Its registration status based on the recorded expiry date is Valid, with the licence valid until 23 June 2031. The product is registered to WIGO HEALTH INDONESIA - INDONESIA. BPOM first approved this registration in June 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 30 June 2026. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: newaero
Packaging: DUS, 4 AMPLOP @ 1 BLISTER @ 14 TABLET SALUT SELAPUT (56 TABLET SALUT SELAPUT)
Department: Direktorat Registrasi Obat
Data Last Updated: 30 June 2026

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

WIGO HEALTH INDONESIA - INDONESIA
KODYA JAKARTA TIMUR
NPWP: 010615250052000
owner
View profile →

Manufacturing Sites

WIGO HEALTH INDONESIA - INDONESIA
KODYA JAKARTA TIMUR
primary
View profile →

Ingredients (1)

ENZALUTAMIDE

Market Intelligence

Owner Portfolio: WIGO HEALTH INDONESIA - INDONESIA holds 75 BPOM registrations
Manufacturer Scale: WIGO HEALTH INDONESIA - INDONESIA produces 75 registered products
Registration Age: Registered for 4 months

FDA Cross-Reference

via openFDA

Generic Name: ENZALUTAMIDE
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?